Error loading player: No playable sources found

AM23-MN-26-O

AM23-MN-26-O: ASHI/AABB Joint Session: The Problem with Platelets: How Perspectives of Various Practitioners Involved in Platelet Support of Refractory Patients Has Led to Continuing Controversies (Enduring)

Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)
$30
Standard Price
Members save $5

In this session, we will demonstrate how various practitioners caring for the same immune refractory patient can have widely different practices regarding platelet support for the patient. We will show how this can lead to delays in treatment, less than effective treatment for the patient, and a waste of a scarce resource. We will propose current best practices and better communication among the practitioners involved. Additionally, we will introduce Platelet Refractory Evaluation Workgroup, which has been formed to outline the perceptions, expectations, limitations, and efficacy of managing platelet refractory patients.

Learning Objectives

  • Explain the perspectives of the hematologist ordering platelets, the transfusion service issuing the platelet product, HLA laboratory performing HLA antibody testing and the blood collection center providing platelets
  • List the tests available that provide appropriate information leading to selection of the best platelet products for transfusion
  • Describe the testing used to monitor platelet effectiveness
  • Describe algorithms that utilize HLA testing to select the optimal platelet products for platelet immune refractory patients

Moderators

Speaker Image for Lesley Kresie
Medical Director of Technical Services, Carter BloodCare

Speakers

Speaker Image for Patricia Kopko
Medical Director, University of California San Diego
Speaker Image for Sandhya Panch
Director of Transfusion, Clinical Research Division, Fred Hutchinson Cancer Center
Speaker Image for Harold Sullivan
Co-Director of HLA Laboratory; Director of Cellular Therapy Laboratory, Emory University School of Medicine
Speaker Image for Ralph Vassallo
EVP / Chief Medical & Scientific Officer, Vitalant

Tracks

Related Products

Thumbnail for AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…
Thumbnail for AM24-ST-17-O: Oral Abstracts - Blood Donor Issues (Enduring)
AM24-ST-17-O: Oral Abstracts - Blood Donor Issues (Enduring)
Oral Abstract session about blood donor issues…
Thumbnail for AM24-ST-06-O: Oral Abstracts - Infectious Diseases, Viruses (Enduring)
AM24-ST-06-O: Oral Abstracts - Infectious Diseases, Viruses (Enduring)
Oral Abstracts about Infectious Diseases and Viruses